Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call Transcript
2025-08-14 13:29:53 ET
Brainstorm Cell Therapeutics Inc. (BCLI)
Q2 2025 Earnings Conference Call
August 14 2025, 08:30 AM ET
Company Participants
Alla Patlis - Interim CFO & Controller
Chaim Lebovits - President & CEO
Ibrahim Dagher - Executive VP & Chief Medical Officer
Conference Call Participants
David Bautz - Zacks Small-Cap Research
Michael Wood - Lifesci Advisors, LLC
Presentation
Operator
Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this call is being recorded. And I would now like to introduce your host for today's call, Michael Wood of LifeSci Advisors. Mr. Wood, you may begin....
Read the full article on Seeking Alpha
For further details see:
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call Transcript
NASDAQ: BCLI
BCLI Trading
-6.95% G/L:
$0.7416 Last:
22,410 Volume:
$0.79356 Open:
